JAMA psychiatry 79(3), 260-269 (2022). doi:10.1001/jamapsychiatry.2021.3799 JAMA psychiatry, vol. 79, no. 3, pp. 260-269 JAMA Psychiatry Genetics Workstream of the Schizophrenia Treatment Resistance and Therapeutic Advances (STRATA) Consortium and the Schizophrenia Working Group of the Psychiatric Genomics Consortium (PGC) 2022, ' Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia ', JAMA psychiatry, vol. 79, no. 3, pp. 260-269 . https://doi.org/10.1001/jamapsychiatry.2021.3799 JAMA Psychiatry 2022; 79 (3): 260-269 Pardiñas, A F, Smart, S E, Willcocks, I R, Holmans, P A, Dennison, C A, Lynham, A J, Legge, S E, Baune, B T, Bigdeli, T B, Cairns, M J, Corvin, A, Fanous, A H, Frank, J, Kelly, B, McQuillin, A, Melle, I, Mortensen, P B, Mowry, B J, Pato, C N, Periyasamy, S, Rietschel, M, Rujescu, D, Simonsen, C, St Clair, D, Tooney, P, Wu, J Q, Andreassen, O A, Kowalec, K, Sullivan, P F, Murray, R M, Owen, M J, Maccabe, J H, O'Donovan, M C, Walters, J T R, The Genetics Workstream of the Schizophrenia Treatment Resistance and Therapeutic Advances (STRATA) Consortium & The Schizophrenia Working Group of the Psychiatric Genomics Consortium (PGC) 2022, ' Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants with Treatment Resistance in Schizophrenia ', JAMA Psychiatry, vol. 79, no. 3, pp. 260-269 . https://doi.org/10.1001/jamapsychiatry.2021.3799 Genetics Workstream of the Schizophrenia Treatment Resistance and Therapeutic Advances (STRATA) Consortium and the Schizophrenia Working Group of the Psychiatric Genomics Consortium (PGC) 2022, ' Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia ', JAMA Psychiatry . https://doi.org/10.1001/jamapsychiatry.2021.3799